1.00
price down icon3.85%   -0.04
pre-market  Pre-market:  1.02   0.02   +2.00%
loading

Tenaya Therapeutics Inc Stock (TNYA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
7.37%
33.76
31.45 30.92 35.10 33.72
Depreciation and Amortization
0.00%
2.20
2.20 2.20 2.20 2.10
Operating Income/Loss
7.37%
-33.76
-31.45 -30.92 -35.10 -33.72
Nonoperating Income/Loss
1.52%
1.534
1.511 1.777 1.835 1.986
Income/Loss From Continuing Operations Before Tax
7.66%
-32.23
-29.93 -29.14 -33.27 -31.74
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
7.66%
-32.23
-29.93 -29.14 -33.27 -31.74
Net Income/Loss
7.66%
-32.23
-29.93 -29.14 -33.27 -31.74
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
39,036%
80.98
0.2069 73.92 73.40 73.10
Diluted Average Shares
39,036%
80.98
0.2069 73.92 73.40 73.10
Basic Earnings Per Share
0.00%
-0.40
-0.40 -0.39 -0.45 -0.43
Diluted Earnings Per Share
0.00%
-0.40
-0.40 -0.39 -0.45 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):